At-Home Morning Bright Light Treatment for Chronic Nociplastic Pain: Protocol for a Randomized Clinical Trial
JMIR Research Protocols · 2025
DOI: 10.2196/75060 ↗At a glance
Randomisierte kontrollierte Studie in JMIR Research Protocols, 2025. Written by Helen J Burgess and 12 co-authors. Institution: Sleep and Circadian Research Laboratory, Department of Psychiatry, University of Michigan, Ann Arbor, MI, United States. Major MEDLINE topics: Phototherapy, Fibromyalgia, Chronic Pain, Pain Management. Cited 1 times so far (Crossref); 86 references. The full text is freely available in PubMed Central. Funded by: NINR NIH HHS, NCATS NIH HHS.
Abstract (original language)
Background
Fibromyalgia, the quintessential nociplastic pain condition, affects more than 20 million Americans and results in significant disability, lost productivity, and poor quality of life, with profound individual and societal cost. As pharmacological treatment approaches offer only modest benefits and result in a high rate of discontinuation due to adverse effects, nonpharmacological interventions such as physical therapy, exercise, and cognitive behavioral therapy are recommended. However, cost and access to these treatments can create barriers to care, and engagement can be problematic. Morning bright light treatment is a promising option for improving fibromyalgia symptoms, with early studies indicating clinically meaningful improvements in fibromyalgia symptoms.
Objective
This study aims to prospectively examine the potential benefits and active elements of morning bright light treatment and sleep timing stabilization for individuals with fibromyalgia in the largest randomized controlled trial to date.
Methods
We will recruit 390 adults who meet diagnostic criteria for fibromyalgia and report at least mild symptoms. Participants will be randomized to one of three groups: 4 weeks of morning bright light treatment (1 hour per day, using a commercially available Re-timer device), 4 weeks of sleep timing stabilization alone (a component of morning bright light treatment, some benefit anticipated), or 4 weeks of treatment as usual, with equivalent study contact. Patient-reported outcomes of function and pain will be assessed before and after treatment, with mood, sleep quality, and morningness-eveningness examined as potential mediators of treatment effects. Social determinants of health risk will be examined as a potential moderator influencing baseline symptoms, treatment engagement, and treatment response.
Results
Data collection began in September 2024 and is projected to end in March 2029.
Conclusions
Morning bright light treatment is well-positioned to be an effective nonpharmacological treatment for fibromyalgia with minimal side effects. The study findings will provide important insights relevant to the development of morning bright light treatment as an accessible treatment for chronic nociplastic pain. Trial Registration ClinicalTrials.gov NCT06567886; https://clinicaltrials.gov/study/NCT06567886 International Registered Report Identifier (IRRID) DERR1-10.2196/75060
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Sleep and Circadian Research Laboratory, Department of Psychiatry, University of Michigan, Ann Arbor, MI, United States.
- Department of Anesthesiology, University of Michigan, Ann Arbor, MI, United States.
- Department of Physical Medicine & Rehabilitation, University of Florida, Gainesville, FL, United States.
- Pain Research and Intervention Center of Excellence, University of Florida, Gainesville, FL, United States.
- Department of Anesthesiology, Division of Pain Medicine, University of Florida, Gainesville, FL, United States.
- Department of Biostatistics, University of Michigan, Ann Arbor, MI, United States.
ORCID profiles: Helen J Burgess, Allie A Rodgers, Kiley A McNeil, Jackson Mott, Agnes Fejer, Tori Dereski, Muneer Rizvydeen, Kimberly T Sibille, Hyungjin Myra Kim, Cherie Cofield, John W Burns, Sana Shaikh, Afton L Hassett
Funding
- NINR NIH HHS
- NCATS NIH HHS
Cite
APA
Burgess, H. J., Rodgers, A. A., McNeil, K. A., Mott, J., Fejer, A., Dereski, T., Rizvydeen, M., Sibille, K. T., Kim, H. M., Cofield, C., Burns, J. W., Shaikh, S., & Hassett, A. L. (2025). At-Home Morning Bright Light Treatment for Chronic Nociplastic Pain: Protocol for a Randomized Clinical Trial. JMIR Research Protocols. https://doi.org/10.2196/75060
Vancouver
Burgess HJ, Rodgers AA, McNeil KA, Mott J, Fejer A, Dereski T, et al. At-Home Morning Bright Light Treatment for Chronic Nociplastic Pain: Protocol for a Randomized Clinical Trial. JMIR Research Protocols. 2025. doi:10.2196/75060
BibTeX
@article{Burgess2025,
author = {Burgess, Helen J and Rodgers, Allie A and McNeil, Kiley A and Mott, Jackson and Fejer, Agnes and Dereski, Tori and Rizvydeen, Muneer and Sibille, Kimberly T and Kim, Hyungjin Myra and Cofield, Cherie and Burns, John W and Shaikh, Sana and Hassett, Afton L},
title = {At-Home Morning Bright Light Treatment for Chronic Nociplastic Pain: Protocol for a Randomized Clinical Trial},
journal = {JMIR Research Protocols},
year = {2025},
doi = {10.2196/75060}
}
EUVIMED